These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 27802546

  • 1. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
    Siprashvili Z, Nguyen NT, Gorell ES, Loutit K, Khuu P, Furukawa LK, Lorenz HP, Leung TH, Keene DR, Rieger KE, Khavari P, Lane AT, Tang JY, Marinkovich MP.
    JAMA; 2016 Nov 01; 316(17):1808-1817. PubMed ID: 27802546
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
    So JY, Nazaroff J, Iwummadu CV, Harris N, Gorell ES, Fulchand S, Bailey I, McCarthy D, Siprashvili Z, Marinkovich MP, Tang JY, Chiou AS.
    Orphanet J Rare Dis; 2022 Oct 17; 17(1):377. PubMed ID: 36253825
    [Abstract] [Full Text] [Related]

  • 3. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
    Eichstadt S, Barriga M, Ponakala A, Teng C, Nguyen NT, Siprashvili Z, Nazaroff J, Gorell ES, Chiou AS, Taylor L, Khuu P, Keene DR, Rieger K, Khosla RK, Furukawa LK, Lorenz HP, Marinkovich MP, Tang JY.
    JCI Insight; 2019 Oct 03; 4(19):. PubMed ID: 31578311
    [Abstract] [Full Text] [Related]

  • 4. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT, Cogan J, Hou Y, Lyu C, Marinkovich MP, Keene D, Chen M.
    J Clin Invest; 2017 Aug 01; 127(8):3028-3038. PubMed ID: 28691931
    [Abstract] [Full Text] [Related]

  • 5. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
    Jacków J, Titeux M, Portier S, Charbonnier S, Ganier C, Gaucher S, Hovnanian A.
    J Invest Dermatol; 2016 Jul 01; 136(7):1346-1354. PubMed ID: 26994967
    [Abstract] [Full Text] [Related]

  • 6. Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.
    Woodley DT, Hao M, Kwong A, Levian B, Cogan J, Hou Y, Mosallaei D, Kleinman E, Zheng K, Chung C, Kim G, Peng D, Chen M.
    Br J Dermatol; 2024 Jul 16; 191(2):267-274. PubMed ID: 38366625
    [Abstract] [Full Text] [Related]

  • 7. Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa.
    Berthault C, Gaucher S, Gouin O, Schmitt A, Chen M, Woodley D, Titeux M, Hovnanian A, Izmiryan A.
    J Invest Dermatol; 2024 Jun 16; 144(6):1322-1333.e13. PubMed ID: 38043638
    [Abstract] [Full Text] [Related]

  • 8. Histological and molecular restoration of type VII collagen in Recessive dystrophic epidermolysis bullosa mouse skin by topical injection of keratinocyte-like cells differentiated from human adipose-derived mesenchymal stromal cells.
    Matsuda A, Hasegawa T, Ikeda Y, Wada A, Ikeda S.
    J Dermatol Sci; 2024 Jul 16; 115(1):42-50. PubMed ID: 38876908
    [Abstract] [Full Text] [Related]

  • 9. Collagen VII Expression Is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes.
    Supp DM, Hahn JM, Combs KA, McFarland KL, Schwentker A, Boissy RE, Boyce ST, Powell HM, Lucky AW.
    Cell Transplant; 2019 Jul 16; 28(9-10):1242-1256. PubMed ID: 31271052
    [Abstract] [Full Text] [Related]

  • 10. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
    Chen M, Kasahara N, Keene DR, Chan L, Hoeffler WK, Finlay D, Barcova M, Cannon PM, Mazurek C, Woodley DT.
    Nat Genet; 2002 Dec 16; 32(4):670-5. PubMed ID: 12426566
    [Abstract] [Full Text] [Related]

  • 11. Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes.
    Latella MC, Cocchiarella F, De Rosa L, Turchiano G, Gonçalves MAFV, Larcher F, De Luca M, Recchia A.
    J Invest Dermatol; 2017 Apr 16; 137(4):836-844. PubMed ID: 28027893
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
    van den Akker PC, van Essen AJ, Kraak MM, Meijer R, Nijenhuis M, Meijer G, Hofstra RM, Pas HH, Scheffer H, Jonkman MF.
    J Dermatol Sci; 2009 Oct 16; 56(1):9-18. PubMed ID: 19665875
    [Abstract] [Full Text] [Related]

  • 15. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
    Gache Y, Baldeschi C, Del Rio M, Gagnoux-Palacios L, Larcher F, Lacour JP, Meneguzzi G.
    Hum Gene Ther; 2004 Oct 16; 15(10):921-33. PubMed ID: 15585108
    [Abstract] [Full Text] [Related]

  • 16. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa.
    Murauer EM, Gache Y, Gratz IK, Klausegger A, Muss W, Gruber C, Meneguzzi G, Hintner H, Bauer JW.
    J Invest Dermatol; 2011 Jan 16; 131(1):74-83. PubMed ID: 20720561
    [Abstract] [Full Text] [Related]

  • 17. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.
    Venugopal SS, Yan W, Frew JW, Cohn HI, Rhodes LM, Tran K, Melbourne W, Nelson JA, Sturm M, Fogarty J, Marinkovich MP, Igawa S, Ishida-Yamamoto A, Murrell DF.
    J Am Acad Dermatol; 2013 Dec 16; 69(6):898-908.e7. PubMed ID: 24075228
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.
    Gurevich I, Agarwal P, Zhang P, Dolorito JA, Oliver S, Liu H, Reitze N, Sarma N, Bagci IS, Sridhar K, Kakarla V, Yenamandra VK, O'Malley M, Prisco M, Tufa SF, Keene DR, South AP, Krishnan SM, Marinkovich MP.
    Nat Med; 2022 Apr 16; 28(4):780-788. PubMed ID: 35347281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.